The Breathing as One - Boehringer Ingelheim Canada/CIHR-ICRH: COPD Catalyst Grant competition promotes innovative research related to the treatment/quality of life, mechanism of disease, and health care services for COPD. Catalyst grants are scalable research studies that can be pilot studies, feasibility studies, translational studies, and novel and innovative approaches.
Applicants should be creative and think broadly. To this end, submissions to this grant competition should only be made for new project ideas and not the continuation of an existing project.
Even though your long-term goals for the project may extend beyond the means and timeline of this grant, within one year, the results of the catalyst projects should enable the development of funding proposals that are eligible for submission to national or international peer-reviewed competitions.
Funding for this competition has been provided by a donation from Boehringer Ingelheim Canada to The Lung Association's Breathing as One campaign for lung research and a partnership with the CIHR–ICRH. Boehringer Ingelheim Canada is not involved with adjudication or the funding decisions for this competition.
The partnership with Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health (ICRH) increased the total funding amount available for the 2020 competition to $120,000. The maximum amount per grant is $30,000. The funding is for one year and is non-renewable.